DNER and steatosis: During the computational analysis, we identified significant inverse correlation relationships between BET compounds and gene expression signatures of steatosis, liver fibrosis, and patient-derived NASH (Supplementary Table S1), suggesting that BET compounds may have utility for treatment of these conditions.